0000899866-16-000361.txt : 20160927 0000899866-16-000361.hdr.sgml : 20160927 20160927171416 ACCESSION NUMBER: 0000899866-16-000361 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160923 FILED AS OF DATE: 20160927 DATE AS OF CHANGE: 20160927 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000899866 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133648318 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 COLLEGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 2032722596 MAIL ADDRESS: STREET 1: 100 COLLEGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NORBY R DOUGLAS CENTRAL INDEX KEY: 0001227001 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27756 FILM NUMBER: 161905178 MAIL ADDRESS: STREET 1: C/O MAGNACHIP SEMICONDUCTOR, INC. STREET 2: 20400 STEVENS CREEK BOULEVARD, SUITE 370 CITY: CUPERTINO STATE: CA ZIP: 95014 4 1 wf-form4_147501083422588.xml FORM 4 X0306 4 2016-09-23 0 0000899866 ALEXION PHARMACEUTICALS INC ALXN 0001227001 NORBY R DOUGLAS C/O ALEXION PHARMACEUTICALS, INC 100 COLLEGE STREET NEW HAVEN CT 06510 1 0 0 0 Common Stock, par value $.0001 per share 2016-09-23 4 M 0 7202 128.81 D 11174 D Common Stock, par value $.0001 per share 2016-09-23 4 M 0 2800 130.03 D 8374 D Common Stock, par value $.0001 per share 2016-09-23 4 M 0 3724 131.10 D 4650 D Common Stock, par value $.0001 per share 2016-09-23 4 M 0 1774 131.97 D 2876 D The transactions reported by this Form 4 are made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $128.35 - $129.35. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $129.35 - $130.35. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $130.56 - $131.56. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $131.66 - $132.66. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. /s/ Michael Greco, Attorney-in-Fact for R. Douglas Norby 2016-09-27